Q1FY27 · Consolidated

RPPL pairs demand-led production growth with a 14.01% Q1 margin

Management cited sustained demand, improving product mix and capacity utilisation, while the wind-solar project is expected to generate annual savings of Rs 1.75 cr.

By Ashutosh

Filed 05 Aug 2026, 14:07 IST · RPPL (RPPL)

Key takeaways

  • RPPL's consolidated Q1FY27 operating profit of Rs 14.42 cr came at a 14.01% operating margin, with management linking the quarter to demand, product mix and capacity utilisation.
  • Injection moulding production increased 52.00% YoY, while the presentation said capacity had reached 5,800 MT from 1,000 MT in FY23.
  • Net profit of Rs 7.26 cr included a non-operating contribution from Rs 2.10 cr of other income, with the tax rate at 22.74%.

Demand and mix supported the consolidated Q1 performance

RPPL reported consolidated Q1FY27 revenue of Rs 102.91 cr and operating profit of Rs 14.42 cr, indicating that earnings were generated primarily through operations. Management said the quarter reflected sustained customer demand, an improving product mix, strong capacity utilisation and operational efficiency.

Injection moulding scaled up as applications expanded

The company said injection moulding production increased 52.00% YoY, reflecting customer demand and expanding applications. The presentation said injection moulding capacity rose 5.8 times from 1,000 MT in FY23 to 5,800 MT in Q1FY27. It also said Olive Ecopak has coating capacity of 27,000 MTPA and finished-goods capacity of 15,000 MTPA.

Other income was a visible part of pre-tax earnings

Other income of Rs 2.10 cr sat alongside profit before tax of Rs 9.39 cr, so the quarter included a non-operating contribution to pre-tax earnings. The tax rate was 22.74%, while interest and depreciation were Rs 2.44 cr and Rs 4.69 cr respectively. Management said the approximately 1.9 MW group captive wind-solar arrangement is expected to become operational by October 2026 and generate annual savings of around Rs 1.75 cr.

Q1FY27 at a glance

Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.

Line itemQ1FY27
Revenue₹103 cr
Other income₹2 cr
Expenses₹88 cr
Operating profit₹14 cr
Operating margin (%)14.01%
Interest₹2 cr
Depreciation₹5 cr
Profit before tax₹9 cr
Tax₹2 cr
Net profit₹7 cr
EPS (₹)₹0.98

What management said

From the company’s own investor presentation. Each point is checked against the source document before it appears here.

This quarter

  • Injection moulding production increased 52% year on year, reflecting strong customer demand and expanding applications.
  • The first quarter of FY27 reflected sustained customer demand, an improving product mix and strong capacity utilisation.

Guidance & outlook

  • The group captive wind-solar arrangement is expected to become operational by October 2026.
  • The wind-solar project is expected to generate annual savings of around ₹1.75 crore.

Expansion

  • Injection moulding capacity increased 5.8 times from 1,000 MT in FY23 to 5,800 MT in Q1FY27.
  • Olive Ecopak has coating capacity of 27,000 MTPA and finished goods capacity of 15,000 MTPA.

New products

  • Olive Ecopak has commercialised more than 150 SKUs across paper-based food packaging applications.

New initiatives

  • The company is advancing its sustainability initiatives through a group captive wind-solar arrangement of approximately 1.9 MW.

Competition

  • The company says it was the first in India to introduce 11-layer rigid PP/EVOH and PS/EVOH barrier packaging.

Problems & risks

  • Export revenue increased despite temporary geopolitical disruptions.

What to watch

  • Whether consolidated operating margin stays above 14.01%.
  • Whether injection moulding production sustains the 52.00% YoY increase.
  • Progress toward management's October 2026 operational date for the wind-solar arrangement and its stated Rs 1.75 cr annual savings.

Figures are as filed by the company with the NSE and are reproduced automatically. Educational market commentary only — not investment advice and not a recommendation to buy or sell any security. Results filed 5 Aug '26.